Remedy · drug
Sitagliptin
Also: Zituvimet
A DPP-4 inhibitor antidiabetic drug.
Evidence by condition
Each grade reflects the research for Sitagliptin and that condition specifically.
No graded conditions recorded yet.
Sitagliptin is a DPP-4 inhibitor antidiabetic drug. This is a reference stub — its uses and interactions are not yet curated here.
Source: U.S. FDA drug labeling via openFDA (public domain).